Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 123,856 | 111,684 | 83,433 | 37,098 | 0 |
| Cost of Goods | 7,805 | 6,447 | 601 | 2,225 | N/A |
| Gross Profit | 116,051 | 105,237 | 82,832 | 34,873 | N/A |
| Operating Expenses | 71,823 | 53,843 | 55,940 | 51,697 | 60,502 |
| Operating Income | 45,033 | 51,841 | 27,493 | -16,599 | -60,502 |
| Interest Expense | 4,483 | 4,469 | 4,433 | 4,216 | 2,434 |
| Other Income | 721 | 518 | 558 | 811 | 340 |
| Pre-tax Income | 41,271 | 47,890 | 23,618 | -20,004 | -62,596 |
| Income Tax | 2,044 | 847 | 51 | N/A | N/A |
| Net Income Continuous | 39,227 | 47,043 | 23,567 | -20,004 | -62,596 |
| Net Income | $39,227 | $47,043 | $23,567 | $-20,004 | $-62,596 |
| EPS Basic Total Ops | 0.57 | 0.67 | 0.34 | -0.29 | -0.93 |
| EPS Basic Continuous Ops | 0.57 | 0.67 | 0.34 | -0.29 | -0.93 |
| EPS Diluted Total Ops | 0.57 | 0.63 | 0.32 | -0.29 | -0.93 |
| EPS Diluted Continuous Ops | 0.59 | 0.60 | 0.32 | -0.29 | -0.93 |
| EBITDA(a) | $46,088 | $52,680 | $28,167 | $-15,908 | $-59,889 |